Aberrant methylation of the estrogen receptor and E-cadherin 5′ CpG islands increases with malignant progression in human breast cancer

Cancer Research

Volumn 60, Issue 16, 2000, Pages 4346-4348

  Nass, Sharyl J ^a,d   Herman, James G ^a   Gabrielson, Edward ^a   Iversen, Philip W ^c   Parl, Fritz F ^b   Davidson, Nancy E ^a   Graff, Jeremy R ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d NATIONAL ACADEMY OF SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; UVOMORULIN;

ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CARCINOMA IN SITU; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT TRANSFORMATION; METASTASIS; PRIORITY JOURNAL;

BREAST NEOPLASMS; CADHERINS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CPG ISLANDS; DISEASE PROGRESSION; DNA METHYLATION; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; NEOPLASM METASTASIS; RECEPTORS, ESTROGEN; TUMOR CELLS, CULTURED;

EID: 0034662645     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Multistep carcinogenesis of breast cancer and tumour heterogeneity
2. The cellular basis of tumor progression
3. Alterations in DNA methylation: A fundamental aspect of neoplasia
4. Cancer epigenetics comes of age
5. Hormone receptors: Their role in predicting prognosis and response to endocrine therapy
6. The E-cadherin/catenin complex in invasion and metastasis
7. E-cadherin quantitative immunocytochemical assays in breast carcinomas
8. E-cadherin (E-cad) expression in ductal carcinoma in situ (DCIS) of the breast
9. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer
10. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer
11. The tumor-suppressor function of E-cadherin
12. Mechanisms of inactivation of E-cadherin in breast cancer cell lines
13. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells
14. Methylation of estrogen and progesterone receptor gene 5′ CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors
15. Mapping of the ER gene CpG island methylation by methylation-specific polymerase chain reaction
16. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas
17. Mapping patterns of CpG island methylation in normal and neoplastic cells implicated both upstream and downstream regions in de novo methylation
18. Methylation patterns of the E-cadherin 5′CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression
19. Estrogens as a cause of human cancer: The Richard and Hinda Rosenthal Foundation Award Lecture
20. Tamoxifen for early breast cancer: An overview of the randomized trials
21. Cancer metastasis: Negative regulation by an invasion-suppressor complex
22. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression
23. MSP: A novel PCR assay for methylation status of CpG islands
24. Heterogeneity of estrogen receptor expression in normal and malignant breast tissue